The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 112.50
Bid: 110.00
Ask: 115.00
Change: 0.00 (0.00%)
Spread: 5.00 (4.545%)
Open: 112.50
High: 114.00
Low: 112.50
Prev. Close: 112.50
EAH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Regulatory Approval

22 Jan 2018 07:00

ECO Animal Health Group plc

(AIM: EAH)

ECO RECEIVES UKRANIAN MARKETING AUTHORISATIONS FOR AIVLOSIN® FOR PIGS AND POULTRY

ECO Animal Health Group plc is pleased to announce that its subsidiary ECO Animal Health Limited (ECO) has received a number of marketing authorisations for Aivlosin® from the Department for Food Safety and Veterinary from the State Service of Ukraine on Food Safety and Consumer Protection.

Aivlosin ® , ECO’s patented antimicrobial, is used for the treatment of a variety of economically important respiratory and enteric (gut) diseases in pigs and poultry.

These authorisations, which are for the use of Aivlosin® 625 mg/g water soluble granules and Aivlosin® 42.5 mg/g premix for both pigs and poultry, also allow ECO to start selling Aivlosin® in the Ukraine for the medication of drinking water or for mixing into feed, for the treatment of infections caused by Mycoplasma in poultry laying eggs for human consumption, with a zero day drug withdrawal period for eggs.

These new treatments meet all the guidelines for the responsible use of antimicrobials. Importantly, with global concerns about the use of antibiotics in food production animals, these treatments are under the control of veterinarians, available under prescription only and have low, highly effective therapeutic dose rates, a short treatment duration and a zero day or very short drug withholding period.

Peter Lawrence, Chairman of ECO, commented “We are extremely pleased to receive these marketing authorisations for Aivlosin® in the Ukraine, the sixteenth largest egg producing country and one that is ranked just outside the top twenty globally for pork production.”

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

Contacts:

ECO Animal Health Group plc

Peter Lawrence   020 8336 6190
Marc Loomes 020 8447 6906
Spiro Financial
Anthony Spiro 020 8336 6196
N+1 Singer (Nominated Adviser) 020 7496 3000
Mark Taylor, Brough Ransom
Peel Hunt LLP (Joint Broker)
James Steel, Dr Christopher Golden 020 7418 8900
 

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders

View source version on businesswire.com: http://www.businesswire.com/news/home/20180121005079/en/

Copyright Business Wire 2018

Date   Source Headline
15th Apr 201512:12 pmBUSIssue of Equity
14th Apr 201511:47 amBUSIssue of Equity
13th Apr 20157:00 amBUSTrading Statement
17th Mar 201510:50 amBUSTransaction in Own Shares
11th Mar 20153:43 pmBUSDirector/PDMR Shareholding - Replacement
2nd Mar 20159:37 amBUSIssue of Equity
26th Feb 20159:19 amBUSIssue of Equity
23rd Feb 20155:00 pmBUSHolding(s) in Company
18th Feb 20159:20 amBUSDirector/PDMR Shareholding
12th Feb 20153:24 pmBUSCirc re.Share buy-back programme
26th Jan 20152:03 pmBUSIssue of Equity
22nd Jan 201510:56 amBUSDirector/PDMR Shareholding
21st Jan 20159:22 amBUSHolding(s) in Company
13th Jan 20154:54 pmBUSIssue of Equity
22nd Dec 20141:26 pmBUSDirectorate Change
3rd Dec 20147:00 amBUSHalf-yearly Report
31st Oct 20149:18 amBUSHolding(s) in Company
18th Sep 201411:07 amBUSResult of AGM
29th Aug 201410:35 amBUSDirector/PDMR Shareholding
30th Jul 201410:24 amBUSCirc re.Posting of Annual Report and Notice of Meeting
28th Jul 20147:00 amBUSFinal Results
10th Jun 20147:00 amBUSChange of Nomad
13th Mar 20149:50 amBUSIssue of Equity
25th Feb 20149:06 amBUSRegulatory Approval
25th Feb 20147:00 amBUSRegulatory Application
3rd Feb 20147:00 amBUSRegulatory Approval
28th Jan 201412:45 pmBUSHolding(s) in Company
27th Jan 20147:00 amBUSRegulatory Approval
10th Dec 20137:00 amBUSHalf-yearly Report
2nd Dec 20137:00 amBUSRegulatory Approval
28th Nov 201310:23 amBUSIssue of Equity
28th Nov 20139:22 amBUSHolding(s) in Company
28th Oct 20137:00 amBUSRegulatory Approval
25th Oct 20133:03 pmBUSHolding(s) in Company
24th Oct 20133:04 pmBUSHolding(s) in Company
24th Oct 20132:57 pmBUSIssue of Equity
22nd Oct 20133:03 pmBUSResult of EGM
15th Oct 20131:29 pmBUSCirc re.Issue of Options
3rd Oct 20139:33 amBUSIssue of Equity
25th Sep 201312:38 pmBUSHolding(s) in Company
19th Sep 201311:28 amBUSCirc re. Scrip dividend scheme
6th Sep 20134:16 pmBUSIssue of Equity
28th Aug 201310:09 amBUSCirc re. Issue of options
25th Jul 201311:45 amBUSCirc re.Annual Report and Accounts 2013
12th Jul 20137:00 amBUSFinal Results
26th Apr 20133:47 pmBUSIssue of Equity
5th Mar 20139:36 amBUSIssue of Equity
15th Jan 201312:15 pmBUSIssue of Equity
12th Dec 20127:00 amBUSHalf-yearly Report
26th Nov 20127:00 amBUSRegulatory Approval

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.